Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1995-3-28
|
| pubmed:abstractText |
We measured serum levels of sIL-2R in 28 patients with squamous cell esophageal carcinoma and in 12 controls. Sera for presence of sIL-2R were examined using DAKO Interleukin-2-receptor (CD25) ELISA. The samples were analyzed for CEA and SCC by using IMx System (Abbot). The mean values of sIL-2R in esophageal carcinoma group were significantly increased in comparison with control group. Our results suggest that sIL-2R may be useful in monitoring and prognosis estimation of disease in esophageal carcinoma and could be a valuable addition to the current spectrum of cancer markers.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0028-2685
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
41
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
315-8
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:7870214-Adult,
pubmed-meshheading:7870214-Aged,
pubmed-meshheading:7870214-Carcinoembryonic Antigen,
pubmed-meshheading:7870214-Carcinoma, Squamous Cell,
pubmed-meshheading:7870214-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:7870214-Esophageal Neoplasms,
pubmed-meshheading:7870214-Humans,
pubmed-meshheading:7870214-Male,
pubmed-meshheading:7870214-Middle Aged,
pubmed-meshheading:7870214-Receptors, Interleukin-2
|
| pubmed:year |
1994
|
| pubmed:articleTitle |
Soluble interleukin-2 receptor in serum of patients with esophageal carcinoma.
|
| pubmed:affiliation |
Department of Immunopathology, Medical Academy, Bia?ystok, Poland.
|
| pubmed:publicationType |
Journal Article
|